Mangalam Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE584F01014
  • NSEID: MANGALAM
  • BSEID: 532637
INR
27.54
-1.35 (-4.67%)
BSENSE

Nov 20

BSE+NSE Vol: 48.18 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 138636,
    "name": "Mangalam Drugs",
    "stock_name": "Mangalam Drugs",
    "full_name": "Mangalam Drugs and Organics Ltd",
    "name_url": "stocks-analysis/mangalam-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "27.54",
    "chg": -1.35,
    "chgp": "-4.67%",
    "dir": -1,
    "prev_price": "28.89",
    "mcapval": "45.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532637,
    "symbol": "MANGALAM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE584F01014",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "48.18 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/mangalam-drugs-138636-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Mangalam Drugs Gains 1.38%: 4 Key Factors Driving the Week’s Volatility",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/mangalam-drugs-gains-138-4-key-factors-driving-the-weeks-volatility-4256284",
        "imagepath": "",
        "date": "2026-11-08 16:00:39",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Nov 2:</strong> Golden Cross formation signals potential bullish breakout</p>\n                    <p><strong>Nov 3:</strong> Mojo Score upgraded to Sell from Strong Sell</p>\n                    <p><strong>Nov 6:</strong> Q2 FY27 results reveal mounting losses despite revenue growth</p>\n                    <p><strong>Nov 6:</strong> Stock hits lower circuit amid heavy selling pressure</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.28.92</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">..."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Locks at Lower Circuit With 6.66% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4254418",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/MangalamDrugsan_stocks_hitting_lower_circuit_4254418.png",
        "date": "2026-11-06 14:00:06",
        "description": "At Rs 27.58, sellers were still queuing — but there were no buyers willing to take the other side. Mangalam Drugs and Organics Ltd locked at its lower circuit of 6.66% on 6 Nov 2026, with unfilled sell orders and a frozen price."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Forms Golden Cross Amid Mixed Technical Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-forms-golden-cross-indicating-potential-bullish-breakout-4247921",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/MangalamDrugsan_goldencross_4247921.png",
        "date": "2026-11-02 18:00:11",
        "description": "The 50-day moving average for Mangalam Drugs and Organics Ltd has crossed above the 200-day moving average, creating a golden cross on 2 Nov 2026. Yet, the broader technical indicators and fundamental backdrop present a nuanced picture that tempers the enthusiasm this crossover might otherwise generate."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-4242023",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/MangalamDrugsan_mojoScore_4242023.png",
        "date": "2026-10-28 10:10:25",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 28 October 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-4227775",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/MangalamDrugsan_mojoScore_4227775.png",
        "date": "2026-10-16 10:10:25",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 16 October 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 1.59% Gain — Buyers Queue, Sellers Absent",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-strong-buying-pressure-4220451",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/MangalamDrugsan_stocks_hitting_upper_circuit_4220451.png",
        "date": "2026-10-09 13:00:08",
        "description": "At Rs 34.62, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 10% on 09 Oct 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-4208489",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/MangalamDrugsan_mojoScore_4208489.png",
        "date": "2026-09-29 10:10:18",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 May 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 29 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-4197354",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/MangalamDrugsan_mojoScore_4197354.png",
        "date": "2026-09-18 10:10:25",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 10% Gain — Buyers Queue, Sellers Absent",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-strong-buying-pressure-4189481",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/MangalamDrugsan_stocks_hitting_upper_circuit_4189481.png",
        "date": "2026-09-10 12:00:08",
        "description": "At Rs 34.88, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 10% on 10 Sep 2026, with buyers queuing and no sellers willing to part with shares."
      }
    ],
    "total": 60,
    "sid": "138636",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/mangalam-drugs-and-organics-138636"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI LODR 2015",
      "datetime": "18-Nov-2026",
      "details": "Outcome of Board Meeting pursuant to Regulation 30 of SEBI LODR 2015 to consider and approve of financial restructuring exploring strategic options and convening of EGM of the Company",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI LODR 2015",
      "datetime": "18-Nov-2026",
      "details": "Outcome of Board Meeting pursuant to Regulation 30 of SEBI LODR 2015 to consider and approve of financial restructuring exploring strategic options and convening of EGM of the Company",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 LODR 2015 - Updates",
      "datetime": "18-Nov-2026",
      "details": "Disclosure pursuant to Regulation 30 LODR 2025 for approval and consideration by Board of Directors at Meeting held on 18.11.2026 of the Company for undertaking of Financial Restructuring and exploring of various strategic options and convening of EGM to seek members approval to take fesiable action in the aforesaid matter.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mangalam Drugs and Organics Ltd has declared <strong>5%</strong> dividend, ex-date: 21 Dec 17",
          "dt": "2017-12-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI LODR 2015

18-Nov-2026 | Source : BSE

Outcome of Board Meeting pursuant to Regulation 30 of SEBI LODR 2015 to consider and approve of financial restructuring exploring strategic options and convening of EGM of the Company

Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI LODR 2015

18-Nov-2026 | Source : BSE

Outcome of Board Meeting pursuant to Regulation 30 of SEBI LODR 2015 to consider and approve of financial restructuring exploring strategic options and convening of EGM of the Company

Announcement Under Regulation 30 LODR 2015 - Updates

18-Nov-2026 | Source : BSE

Disclosure pursuant to Regulation 30 LODR 2025 for approval and consideration by Board of Directors at Meeting held on 18.11.2026 of the Company for undertaking of Financial Restructuring and exploring of various strategic options and convening of EGM to seek members approval to take fesiable action in the aforesaid matter.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Mangalam Drugs and Organics Ltd has declared 5% dividend, ex-date: 21 Dec 17

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available